These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1611604)

  • 21. Pilocarpine in radiation-induced xerostomia.
    Rousseau P
    Am J Hosp Palliat Care; 1995; 12(2):38-9. PubMed ID: 7605731
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation-induced xerostomia.
    Chambers MS; Rosenthal DI; Weber RS
    Head Neck; 2007 Jan; 29(1):58-63. PubMed ID: 16906511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial saliva products and drugs to treat xerostomia.
    Wynn RL; Meiller TF
    Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of xerostomia related to radiotherapy for head and neck cancer.
    Kahn ST; Johnstone PA
    Oncology (Williston Park); 2005 Dec; 19(14):1827-32; discussion 1832-4, 1837-9. PubMed ID: 16506635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xerostomia: diagnosis and management.
    Greenspan D
    Oncology (Williston Park); 1996 Mar; 10(3 Suppl):7-11. PubMed ID: 8723427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study.
    Lakshman AR; Babu GS; Rao S
    J Cancer Res Ther; 2015; 11(1):229-33. PubMed ID: 25879367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
    Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Groningen Radiotherapy-Induced Xerostomia questionnaire: development and validation of a new questionnaire.
    Beetz I; Burlage FR; Bijl HP; Hoegen-Chouvalova O; Christianen ME; Vissink A; van der Laan BF; de Bock GH; Langendijk JA
    Radiother Oncol; 2010 Oct; 97(1):127-31. PubMed ID: 20541272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
    Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
    Nakamura N; Sasano N; Yamashita H; Igaki H; Shiraishi K; Terahara A; Asakage T; Nakao K; Ebihara Y; Ohtomo K; Nakagawa K
    Auris Nasus Larynx; 2009 Jun; 36(3):310-3. PubMed ID: 18635328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study.
    Garcia MK; Chiang JS; Cohen L; Liu M; Palmer JL; Rosenthal DI; Wei Q; Tung S; Wang C; Rahlfs T; Chambers MS
    Head Neck; 2009 Oct; 31(10):1360-8. PubMed ID: 19378325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
    Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
    Radiother Oncol; 2007 Oct; 85(1):83-9. PubMed ID: 17391790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME
    J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
    Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands.
    Pimentel MJ; Filho MM; Araújo M; Gomes DQ; DA Costa LJ
    Anticancer Res; 2014 Apr; 34(4):1993-9. PubMed ID: 24692737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral pilocarpine for xerostomia.
    Med Lett Drugs Ther; 1994 Aug; 36(929):76. PubMed ID: 8047049
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.